Publications by authors named "W-K Hofmann"

Claim this Profile
N
Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes- a retrospective matched-pairs analysis.
Katharina Anna Rauhe, Annika Kasprzak, Felicitas Schulz, Kathrin Nachtkamp, Corinna Strupp, Wolf-Karsten Hofmann

Ann Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.
Alexander Streuer, Johann-Christoph Jann, Tobias Boch, Maximilian Mossner, Vladimir Riabov, Wolf-Karsten Hofmann

Ann Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in D816V-Negative Advanced Systemic Mastocytosis.
Nicole Naumann, Martina Rudelius, Johannes Lübke, Deborah Christen, Jakob Bresser, Wolf-Karsten Hofmann

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Techniques to Improve Precise Cell Injection.
Walter Linzenbold, Andreas Fech, Manuela Hofmann, Wilhelm K Aicher, Markus D Enderle

Int J Mol Sci· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine Profile.
Aleksandar Radujkovic, Tobias Boch, Florian Nolte, Daniel Nowak, Claudia Kunz, Wolf-Karsten Hofmann

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antileukemic Efficacy in Vitro of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies.
Vanessa Kohl, Johanna Flach, Nicole Naumann, Susanne Brendel, Helga Kleiner, Wolf-Karsten Hofmann

Cancers (Basel)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATF6 Regulates Cardiac Hypertrophy by Transcriptional Induction of the mTORC1 Activator, Rheb.
Erik A Blackwood, Christoph Hofmann, Michelle Santo Domingo, Alina S Bilal, Anup Sarakki

Circ Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation profiling identifies two subclasses of squamous cell carcinoma related to distinct cells of origin.
Manuel Rodríguez-Paredes, Felix Bormann, Günter Raddatz, Julian Gutekunst, Carlota Lucena-Porcel, Thomas G Hofmann

Nat Commun· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human genome meeting 2016 : Houston, TX, USA. 28 February - 2 March 2016.
A. K. Srivastava, Y. Wang, R. Huang, C. Skinner, T. Thompson, J. Hofmann

Hum Genomics· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-body CT for lymphoma staging: feasibility of halving radiation dose and risk by iterative image reconstruction.
M Meyer, S A Klein, G Brix, C Fink, L Pilz, W K Hofmann

Eur J Radiol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of action of demethylating and immune modulatory agents--introduction.
Wolf-K Hofmann, Carsten Müller-Tidow

Cancer Treat Rev· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of action of demethylating and immune modulatory agents--discussion.
Wolf-K Hofmann

Cancer Treat Rev· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
W-K Hofmann, S Takeuchi, N Takeuchi, E Thiel, D Hoelzer

Leuk Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic syndrome.
Wolf-K Hofmann, H Phillip Koeffler

Annu Rev Med· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic spectrum in the treatment of myelodysplastic syndromes.
Wolf-K Hofmann, Claudia Baldus, Lutz Uharek, Eckhard Thiel

Expert Opin Pharmacother· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic syndromes.
Wolf-Karsten Hofmann, Michael Lübbert, Dieter Hoelzer, H Phillip Koeffler

Hematol J· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
W K Hofmann, G Heil, C Zander, S Wiebe, O G Ottmann

Ann Hematol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of resistance to STI571 (Imatinib) in Philadelphia-chromosome positive acute lymphoblastic leukemia.
Wolf-K Hofmann, Martina Komor, Dieter Hoelzer, Oliver G Ottmann

Leuk Lymphoma· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of the BCR-ABL mutation Glu255Lys prior to STI571 (imatinib) treatment in patients with Ph+ acute lymphoblastic leukemia.
Wolf-Karsten Hofmann, Martina Komor, Barbara Wassmann, Letetia C Jones, Harald Gschaidmeier

Blood· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow.
Wolf-K Hofmann, Sven de Vos, Martina Komor, Dieter Hoelzer, William Wachsman

Blood· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia.
W K Hofmann, G Seipelt, S Langenhan, R Reutzel, D Schott

Ann Hematol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells.
Wolf K Hofmann, Seisho Takeuchi, Malka A Frantzen, Dieter Hoelzer, H Phillip Koeffler

Exp Hematol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Ph(+) acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation.
Wolf-K Hofmann, Letetia C Jones, Nathan A Lemp, Sven de Vos, Harald Gschaidmeier

Blood· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study.
Wolf K Hofmann, Sven de Vos, David Elashoff, Harald Gschaidmeier, Dieter Hoelzer

Lancet· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent loss of heterozygosity in the region of D1S450 at 1p36.2 in myelodysplastic syndromes.
W K Hofmann, S Takeuchi, D Xie, C W Miller, D Hoelzer

Leuk Res· October 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis